Drug Profile
YH 80
Latest Information Update: 11 Feb 2008
Price :
$50
*
At a glance
- Originator Meiji Dairies Corporation
- Class Antiulcers; Cytoprotectives
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Peptic ulcer
Most Recent Events
- 29 Feb 2000 No-Development-Reported for Peptic ulcer in Japan (PO)
- 25 Feb 1997 Preclinical development for Peptic ulcer in Japan (PO)